EverSource Wealth Advisors’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.41K Sell
69
-148
-68% -$17.5K ﹤0.01% 2945
2026
Q1
$22.6K Sell
217
-15
-6% -$1.79K ﹤0.01% 2430
2025
Q4
$28.6K Sell
232
-118
-34% -$15.9K ﹤0.01% 2146
2025
Q3
$54.6K Buy
350
+114
+48% +$16.4K ﹤0.01% 1647
2025
Q2
$28.9K Buy
236
+202
+594% +$24.6K ﹤0.01% 2003
2025
Q1
$4.1K Buy
34
+13
+62% +$1.66K ﹤0.01% 2590
2024
Q4
$2.72K Hold
21
– – ﹤0.01% 2594
2024
Q3
$2.38K Hold
21
– – ﹤0.01% 2491
2024
Q2
$2.13K Hold
21
– – ﹤0.01% 2532
2024
Q1
$1.84K Hold
21
– – ﹤0.01% 2415
2023
Q4
$1.75K Hold
21
– – ﹤0.01% 2205
2023
Q3
$1.59K Hold
21
– – ﹤0.01% 2079
2023
Q2
$1.66K Hold
21
– – ﹤0.01% 2082
2023
Q1
$1.81K Hold
21
– – ﹤0.01% 1960
2022
Q4
$1.7K Hold
21
– – ﹤0.01% 1960
2022
Q3
$2K Buy
+21
New +$2.07K ﹤0.01% 1655

Other funds holding DORM

EverSource Wealth Advisors's DORM Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Dorman Products (DORM) stake by 68% in Q2 2026, selling an estimated $17.5K and leaving 69 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

EverSource Wealth Advisors first reported a position in DORM in Q3 2022 and has held it in 16 quarters since. The position peaked at $54.6K in Q3 2025. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

  • EverSource Wealth Advisors held 69 shares of Dorman Products worth $9.41K as of Q2 2026.
  • EverSource Wealth Advisors sold 148 Dorman Products shares in Q2 2026, an estimated $17.5K.
  • Dorman Products made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2945 holding.
  • EverSource Wealth Advisors first reported a position in Dorman Products in Q3 2022 and has held it in 16 quarters since.
  • EverSource Wealth Advisors's Dorman Products position peaked at $54.6K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.